Phase I study of an immunomodulatory thalidomide analog, CC-4047, in relapsed or refractory multiple myeloma (Q44975171)

From Wikidata
Jump to navigation Jump to search
scientific article published on 12 July 2004
edit
Language Label Description Also known as
English
Phase I study of an immunomodulatory thalidomide analog, CC-4047, in relapsed or refractory multiple myeloma
scientific article published on 12 July 2004

    Statements

    Phase I study of an immunomodulatory thalidomide analog, CC-4047, in relapsed or refractory multiple myeloma (English)
    0 references
    12 July 2004
    3269-3276

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit